Related references
Note: Only part of the references are listed.User guide for the discovery of potential drugs via protein structure prediction and ligand docking simulation
Bilal Shaker et al.
JOURNAL OF MICROBIOLOGY (2020)
Alzheimer's Disease and Vascular Aging JACC Focus Seminar
Marta Cortes-Canteli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The Microbiota-Gut-Brain Axis-Heart Shunt Part II: Prosaic Foods and the Brain-Heart Connection in Alzheimer Disease
Mark Obrenovich et al.
MICROORGANISMS (2020)
Molecular interaction of investigational ligands with human brain acetylcholinesterase
Shazi Shakil
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
The role of mitochondrial defects and oxidative stress in Alzheimer's disease
Badar ul Islam et al.
JOURNAL OF DRUG TARGETING (2019)
The Role of NMDA Receptors in Alzheimer's Disease
Jinping Liu et al.
FRONTIERS IN NEUROSCIENCE (2019)
5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma
Cristina Nastasa et al.
MEDICINA-LITHUANIA (2019)
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy
Eva Ramos et al.
MOLECULES (2019)
Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine
Shams Tabrez et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
The rights of precision drug development for Alzheimer's disease
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease
Federica Cioffi et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunities
Rafi U. Haque et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents
Guy Griebel et al.
SCIENTIFIC REPORTS (2019)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease
Nasimudeen R. Jabir et al.
CNS NEUROSCIENCE & THERAPEUTICS (2018)
Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions
A. Prasanth Saraswati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and beta-amyloid inhibitors for Alzheimer's disease
Samina Khan Yusufzai et al.
CHEMISTRY CENTRAL JOURNAL (2018)
Control of the negative IRES trans-acting factor KHSRP by ubiquitination
Yu-An Kung et al.
NUCLEIC ACIDS RESEARCH (2017)
Protocol for fast screening of multi-target drug candidates: Application to Alzheimer's disease
Nguyen Quoc Thai et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Elucidating Treatment of Alzheimer's Disease via Different Receptors
Badar ul Islam et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
Alzheimer's Disease: Targeting the Cholinergic System
Talita H. Ferreira-Vieira et al.
CURRENT NEUROPHARMACOLOGY (2016)
One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug
Rebecca E. Hughes et al.
FRONTIERS IN NEUROSCIENCE (2016)
Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease
Kenji Fukunaga et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Synopsis on the Linkage of Alzheimer's and Parkinson's Disease with Chronic Diseases
Nasimudeen R. Jabir et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Alzheimer's and Type 2 Diabetes Treatment via Common Enzyme Targeting
Nasimudeen R. Jabir et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
G. Aliev et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Development of Dual Inhibitors against Alzheimer's Disease Using Fragment-Based QSAR and Molecular Docking
Manisha Goyal et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation
Jiansong Fang et al.
ACTA PHARMACEUTICA SINICA B (2014)
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors
Fumiaki Uehara et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs
Ana Martinez
MEDICINAL RESEARCH REVIEWS (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues
Joe Dundas et al.
NUCLEIC ACIDS RESEARCH (2006)
Share Paper
